From the smallest biotech to the biggest pharmaceutical stock, The Motley Fool's Market Checkup covers the health-care sector's biggest headlines, hottest market movers, and Obamacare's ongoing rollout.
In this segment from Thursday's episode, health-care analyst David Williamson discusses trans fats, and a move by the FDA to remove them from the "generally recognized as safe" list. This would then mean that companies would have to apply before being granted permission to include them in foods, and these applications would probably be rejected. David tells investors how this will affect the food industry as a whole, and which companies could be hit the hardest.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.